1. Home
  2. EQ vs UNCY Comparison

EQ vs UNCY Comparison

Compare EQ & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$2.18

Market Cap

157.4M

Sector

Health Care

ML Signal

N/A

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

N/A

Current Price

$5.47

Market Cap

150.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQ
UNCY
Founded
2017
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.4M
150.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EQ
UNCY
Price
$2.18
$5.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.00
$25.67
AVG Volume (30 Days)
495.8K
776.2K
Earning Date
05-25-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,095,000.00
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$582.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$3.72
52 Week High
$3.54
$8.74

Technical Indicators

Market Signals
Indicator
EQ
UNCY
Relative Strength Index (RSI) 44.06 49.76
Support Level $1.97 $5.28
Resistance Level $2.60 $5.92
Average True Range (ATR) 0.18 0.27
MACD 0.02 0.06
Stochastic Oscillator 42.37 56.62

Price Performance

Historical Comparison
EQ
UNCY

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: